Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Considering innate immune responses in SARS-CoV-2 infection and COVID-19
Michael Diamond, John D. Lambris, Jenny P.‐Y. Ting, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 8, pp. 465-470
Open Access | Times Cited: 21

Showing 21 citing articles:

A guide to complement biology, pathology and therapeutic opportunity
Dimitrios C. Mastellos, George Hajishengallis, John D. Lambris
Nature reviews. Immunology (2023) Vol. 24, Iss. 2, pp. 118-141
Closed Access | Times Cited: 95
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 24
Impact of Environmental Factors on Hypertension and Associated Cardiovascular Disease
Francisco J. Rios, Augusto C. Montezano, Lívia L. Camargo, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 9, pp. 1229-1243
Open Access | Times Cited: 25
Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
Obdulio García-Nicolás, Aurélie Godel, Gert Zimmer, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 835-849
Open Access | Times Cited: 22
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
Journal of Virology (2025)
Open Access
The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target
Antonio M. Risitano, Camilla Frieri, Eleonora Urciuoli, et al.
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 262-278
Open Access | Times Cited: 25
Biological effects of COVID-19 on lung cancer: Can we drive our decisions
Beatrice Aramini, Valentina Masciale, Anna Valeria Samarelli, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri‐Bowen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Host factors influencing variable symptoms of COVID-19
Tirasask Pasharawipas
Asian Pacific Journal of Allergy and Immunology (2024)
Open Access | Times Cited: 2
Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity
Wei Dai, Aifang Zhong, Qinghua Qiao, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 13
SARS-CoV-2 epitopes inform future vaccination strategies
Areez Shafqat, Mohamed H. Omer, Omar Ahmad, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
Takuya Tada, Julia Minnee, Nathaniel R. Landau
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 23
Open Access | Times Cited: 6
Multi‐omic and comparative analyses revealed monocyte‐derived alpha‐defensin‐1 correlated with COVID‐19 severity and inhibited SARS‐CoV‐2 infection
Xijing Qian, Bingan Wu, X. Chen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 5
Metallic nanoplatforms for COVID-19 diagnostics: versatile applications in the pandemic and post-pandemic era
Yuqing Li, Jingqi Chen, Jinchao Wei, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Implications of SARS‐CoV‐2 Immunity in the Context of the Pathogenesis of COVID‐19, Immune Evasion of the Virus, and the Effectiveness of Vaccination
Hikmet Akkız
(2024)
Open Access | Times Cited: 1
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Exacerbation of Behcet’s Disease and Pyoderma Gangrenosum Following COVID-19 Infection: A Case Report
Luis Figuero-Pérez, Salvador Vilá
Cureus (2023)
Open Access | Times Cited: 2
Demographic distributions and clinical results of assisted reproduction techniques in Turkey in 2019: a descriptive survey
Can Benlioğlu, Yunus Aydın, Mustafa Bahçeci, et al.
Journal of the Turkish-German Gynecological Association (2024) Vol. 25, Iss. 1, pp. 18-23
Open Access
Emerging severe acute respiratory syndrome coronavirus 2 variants and their impact on immune evasion and vaccine-induced immunity
Ramendra Pati Pandey, Sachin Kumar, Nageswara S. V. Rao, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2024)
Closed Access
Emerging SARS-CoV-2 Variants and Their Impact on Immune Evasion and Vaccine-Induced Immunity
Dablu Lal Gupta, D. N. Rao
(2023)
Open Access | Times Cited: 1
Editorial: The impact of COVID-19 on immune system-related complications in surgical patients
Philip F. Stahel, Sebastian Weckbach, Markus Huber‐Lang, et al.
Frontiers in Surgery (2023) Vol. 10
Open Access
Page 1

Scroll to top